Use of Mouse Renal Adenocarcinoma Cell-containing Agarose-agarose Macrobeads in the Treatment of Patients With End-stage, Treatment-resistant Epithelial-derived Cancer
Phase of Trial: Phase I
Latest Information Update: 02 Jun 2017
Price : $35 *
At a glance
- Drugs Encapsulated cell therapy (Primary)
- Indications Carcinoma
- Focus Adverse reactions
- 02 Jun 2017 Results from NCT01053013 and NCT00283075 studies, presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 10 Mar 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 29 Jan 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.